Literature DB >> 25557625

MicroRNA regulatory networks in idiopathic pulmonary fibrosis.

Kusum V Pandit1, Jadranka Milosevic.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal scarring lung disease of unknown etiology, characterized by changes in microRNA expression. Activation of transforming growth factor (TGF-β) is a key event in the development of IPF. Recent reports have also identified epigenetic modification as an important player in the pathogenesis of IPF. In this review, we summarize the main results of studies that address the role of microRNAs in IPF and highlight the synergistic actions of these microRNAs in regulating TGF-β, the primary fibrogenic mediator. We outline epigenetic regulation of microRNAs by methylation. Functional studies identify microRNAs that alter proliferative and migratory properties of fibroblasts, and induce phenotypic changes in epithelial cells consistent with epithelial-mesenchymal transition. Though these studies were performed in isolation, we identify multiple co-operative actions after assembling the results into a network. Construction of such networks will help identify disease-propelling hubs that can be targeted for therapeutic purposes.

Entities:  

Keywords:  FPI; IPF; TFG-β; TGF-β; epithelial-mesenchymal transition; fibroblastes; fibroblasts; micro-ARN; microRNA; transition épithélium-mésenchyme

Mesh:

Substances:

Year:  2015        PMID: 25557625     DOI: 10.1139/bcb-2014-0101

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  34 in total

1.  miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.

Authors:  Huachun Cui; Jing Ge; Na Xie; Sami Banerjee; Yong Zhou; Veena B Antony; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

2.  Epigenetic and Transcriptomic Regulation of Lung Repair during Recovery from Influenza Infection.

Authors:  Derek A Pociask; Keven M Robinson; Kong Chen; Kevin J McHugh; Michelle E Clay; Grace T Huang; Panayiotis V Benos; Yvonne M W Janssen-Heininger; Jay K Kolls; Vikas Anathy; John F Alcorn
Journal:  Am J Pathol       Date:  2017-02-10       Impact factor: 4.307

3.  MicroRNA Targets for Asthma Therapy.

Authors:  Sabrina C Ramelli; William T Gerthoffer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The Influence of Extracellular RNA on Cell Behavior in Health, Disease and Regeneration.

Authors:  Luai Huleihel; Michelle E Scarritt; Stephen F Badylak
Journal:  Curr Pathobiol Rep       Date:  2017-02-01

5.  Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes.

Authors:  Afshin Ebrahimpour; Samana Shrestha; Mark D Bonnen; N Tony Eissa; Ganesh Raghu; Yohannes T Ghebre
Journal:  J Pharmacol Exp Ther       Date:  2018-11-16       Impact factor: 4.030

Review 6.  The code of non-coding RNAs in lung fibrosis.

Authors:  Huachun Cui; Na Xie; Victor J Thannickal; Gang Liu
Journal:  Cell Mol Life Sci       Date:  2015-05-31       Impact factor: 9.261

Review 7.  Fibrosis: Lessons from OMICS analyses of the human lung.

Authors:  Guoying Yu; Gabriel H Ibarra; Naftali Kaminski
Journal:  Matrix Biol       Date:  2018-03-19       Impact factor: 11.583

8.  MiR-5100 targets TOB2 to drive epithelial-mesenchymal transition associated with activating smad2/3 in lung epithelial cells.

Authors:  Chun-Yan Li; Ya-Hong Wang; Zi-Ying Lin; La-Wei Yang; Sheng-Lan Gao; Tie Liu; Bao-An Zou; Zhan-Chun Pan; Ze-Qing Song; Gang Liu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 9.  Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.

Authors:  Richard Seonghun Nho
Journal:  Drug Dev Res       Date:  2015-08-25       Impact factor: 4.360

10.  Acute downregulation of miR-155 leads to a reduced collagen synthesis through attenuating macrophages inflammatory factor secretion by targeting SHIP1.

Authors:  Longlong Yang; Lingying Liu; Huinan Ying; Yonghui Yu; Donghai Zhang; Huping Deng; Haijun Zhang; Jiake Chai
Journal:  J Mol Histol       Date:  2018-01-12       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.